Literature DB >> 8683522

A survey of the current methods used in the UK to assess pituitary function.

M J Davies1, T A Howlett.   

Abstract

A national survey of the current methods used by specialists to evaluate pituitary function in the UK was performed by postal questionnaire. Seventy-three respondents, of whom 89% were consultants and 80% clinical endocrinologists, returned the questionnaire. Fifty per cent routinely used the insulin stress test (IST) to evaluate the hypothalamo-pituitary-adrenal (HPA) axis, while 50% routinely used tetracosactrin stimulation, there being little overlap between the two groups. This represents a significant change in clinical practice since the last survey in 1988. In those who used ACTH stimulation there was almost an equal split into those who administered the tetracosactrin intramuscularly (45%) or intravenously (47%). Furthermore, either the peak or 60 min cortisol value was used by 71% when interpreting the result of the test, despite the fact that in previous studies only the 30 min cortisol value has been shown to correlate with the IST result. The IST remains the most frequently used method to assess growth hormone reserve in adult subjects. The thyrotrophin-releasing-hormone and gonadotrophin-releasing-hormone tests are still used routinely by approximately a quarter of clinicians. These results provide data that could be used to develop guide-lines for the use of tests to investigate pituitary function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683522      PMCID: PMC1295703          DOI: 10.1177/014107689608900313

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

1.  The pituitary megatest: outdated?

Authors:  C W Burke
Journal:  Clin Endocrinol (Oxf)       Date:  1992-02       Impact factor: 3.478

2.  The adrenocortical response to surgery and insulin-induced hypoglycaemia in corticosteroid-treated and normal subjects.

Authors:  F S Plumpton; G M Besser
Journal:  Br J Surg       Date:  1969-03       Impact factor: 6.939

3.  Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function.

Authors:  J Lindholm; H Kehlet; M Blichert-Toft; B Dinesen; J Riishede
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

4.  Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function.

Authors:  J Lindholm; H Kehlet
Journal:  Clin Endocrinol (Oxf)       Date:  1987-01       Impact factor: 3.478

5.  A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

Authors:  W F Blum; M B Ranke; K Kietzmann; E Gauggel; H J Zeisel; J R Bierich
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

6.  Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient.

Authors:  E Cacciari; P Tassoni; A Cicognani; P Pirazzoli; S Salardi; A Balsamo; A Cassio; S Zucchini; C Colli; D Tassinari
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

7.  A rational approach for assessing the hypothalamo-pituitary-adrenal axis.

Authors:  P M Stewart; J Corrie; J R Seckl; C R Edwards; P L Padfield
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

8.  Normal cortisol response to corticotropin in patients with secondary adrenal failure.

Authors:  S K Cunningham; A Moore; T J McKenna
Journal:  Arch Intern Med       Date:  1983-12

9.  Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man.

Authors:  G M Besser; A S McNeilly; D C Anderson; J C Marshall; P Harsoulis; R Hall; B J Ormston; L Alexander; W P Collins
Journal:  Br Med J       Date:  1972-07-29

10.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

Authors:  F Salomon; R C Cuneo; R Hesp; P H Sönksen
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

View more
  3 in total

1.  Microprolactinoma: medical or surgical treatment as first line approach? The case for medical therapy.

Authors:  D A Rees; J S Davies; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

2.  An evidence-base for laboratory endocrinology?

Authors:  Julian H Barth
Journal:  Clin Biochem Rev       Date:  2008-08

3.  Comparing the utility of 30- and 60-minute cortisol levels after the standard short synacthen test to determine adrenal insufficiency: A retrospective cross-sectional study.

Authors:  Muhammad Imran Butt; Nouf Alzuhayri; Lama Amer; Muhammad Riazuddin; Hadeel Aljamei; Muhammad Sohaib Khan; Mohammed Abufarhaneh; Eman Alrajhi; Anhar Alnassar; Reem Alahmed; Dina Mahmoud Ahmad Aljayar; Fayha Farraj Abothenain; Edward De Vol
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.